More SEC Filings
View Older Stories View Newer Stories-
Form 4 LEXICON PHARMACEUTICALS, For: Feb 28 Filed by: McDermott Wendy
-
Form 6-K Sportradar Group AG For: Mar 03
-
Form 4 LEXICON PHARMACEUTICALS, For: Feb 28 Filed by: Martens Rachel Yap
-
Form 4 LEXICON PHARMACEUTICALS, For: Feb 28 Filed by: Granowitz Craig B
-
Form 4 LEXICON PHARMACEUTICALS, For: Feb 28 Filed by: Gopinathan Suma
-
Form D Intbox-VI-0118 Fund II,
-
Form 4 LEXICON PHARMACEUTICALS, For: Feb 28 Filed by: DeFrancesco Lisa
-
Form 4 LEXICON PHARMACEUTICALS, For: Feb 28 Filed by: Crum Brian T
-
Form D x-MO-0118 Fund I, a seri
-
Form 10-K Scholar Rock Holding For: Dec 31
-
Form D HU-0124 Fund I, a series
-
Form 4 LEXICON PHARMACEUTICALS, For: Feb 28 Filed by: Coiante Scott M
-
Form 10-K Passage BIO, Inc. For: Dec 31
-
Form 8-K CalciMedica, Inc. For: Mar 02
-
Form 4 LEXICON PHARMACEUTICALS, For: Feb 28 Filed by: Exton Michael
-
Form 8-K EVgo Inc. For: Mar 03
-
Form 8-K 908 Devices Inc. For: Mar 03
-
Form 8-K Scholar Rock Holding For: Mar 03
-
Form 8-K TXNM ENERGY INC For: Mar 03
-
Form 8-K Roivant Sciences Ltd. For: Mar 03
-
Form 424B5 TXNM ENERGY INC
-
Form 8-K TARGET CORP For: Mar 03
-
Form D CR-0105 Fund III, a seri
-
Form DEFA14A WEST BANCORPORATION INC
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 424B2 JPMORGAN CHASE & CO
-
Form D HU-0205 Fund I, a series
-
Form 10-K Amylyx Pharmaceuticals, For: Dec 31
-
Form ARS WEST BANCORPORATION INC For: Dec 31
-
Form DEF 14A WEST BANCORPORATION INC For: Dec 31
-
Form 6-K POWERBANK Corp For: Mar 03
-
Form D SY-123, a series of Ange
-
Form 8-K Versant Media Group, For: Mar 03
-
Form 8-K HONEYWELL INTERNATIONAL For: Mar 03
-
Form FWP JPMorgan Chase Financial Filed by: JPMorgan Chase Financial Co. LLC
-
Form FWP JPMORGAN CHASE & CO Filed by: JPMORGAN CHASE & CO
-
Form 6-K PRUDENTIAL PLC For: Mar 03
-
Form D ST-0702 Fund II, a serie
-
Form FWP JPMorgan Chase Financial Filed by: JPMorgan Chase Financial Co. LLC
-
Form 8-K ANI PHARMACEUTICALS INC For: Mar 03
-
Form 8-K Advantage Solutions Inc. For: Mar 03
-
Form FWP JPMORGAN CHASE & CO Filed by: JPMORGAN CHASE & CO
-
Form 8-K Strata Critical Medical, For: Mar 03
-
Form D GH-1119 Fund I, a series
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 424B2 JPMORGAN CHASE & CO
-
Form D SY-1224 Fund I, a series
-
Form 8-K Esperion Therapeutics, For: Mar 02
-
Form 8-K GigaCloud Technology For: Mar 02
-
Form 8-K Amylyx Pharmaceuticals, For: Mar 03

